Viridian Therapeutics had a negative net margin of 490.31% and a negative return on equity of 80.19%. Viridian Therapeutics Stock PerformanceShares of VRDN stock traded up $1.08 during mid-day trading on Friday, hitting $23.59. Viridian Therapeutics has a fifty-two week low of $13.18 and a fifty-two week high of $34.29. Get Viridian Therapeutics alerts:Insider Transactions at Viridian TherapeuticsIn other news, Director Fairmount Funds Management Llc acquired 1,176,470 shares of Viridian Therapeutics stock in a transaction that occurred on Monday, May 11th. Read MoreReceive News & Ratings for Viridian Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viridian Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.